FDA
- Status: approved
intravenous use of sulodexide followed by oral use (intravenous use of sulodexide followed by oral use) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Sun Yat-sen University is the originator. The local marketing authorisation holder may differ — check the official source linked above.